相关实验视频

Updated: Jun 15, 2025

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

动态与静态参数引导液体复苏在败血症患者的影响:一个随机对照试验

Thiti Sricharoenchai¹, Pannarat Saisirivechakun^2,3

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, Thammasat University, Pathum Thani, 12120, Thailand.

|August 26, 2024

概括

动态下腔静脉 (IVC) 在败血症中进行液体复苏的指导没有影响死亡率. 然而,与静态的中央静脉压力 (CVP) 指南相比,这种方法可能会减少冲击持续时间和诺亚上腺素 (NE) 剂量.

科学领域:

临界护理医学临界护理医学
心血管生理学心血管生理学
败血症病理生理学病理生理学

背景情况:

液体复苏对于败血症管理至关重要.
动态变量比静态变量提供更好的流体响应性预测,但不是标准实践.
这项研究将动态下静脉 (IVC) 指导与静态中静脉压 (CVP) 指导在败血症患者中进行比较.

研究的目的:

评估动态IVC引导与静态CVP引导的液体复苏对败血症患者死亡率的影响.
为了比较其他结果,包括复苏目标,冲击持续时间,液体和血管压缩剂的使用,呼吸辅助,停留时间和不良事件.

主要方法:

一个单盲随机对照试验从2016年8月到2020年4月进行.
败血症患者根据APACHE II评分分层,并随机分配到动态IVC或静态CVP指导.
招募了124名患者,每个组62名.

主要成果:

动态IVC组 (34.4%) 和静态CVP组 (45.9%) 的30天死亡率没有显著差异,p=0.196.
动态IVC组显示了显着较短的冲击持续时间 (0.8对1.5天,p=0.001) 和较低的北上腺素 (NE) 剂量 (p=0.008和p=0.017).
在其他测量结果中没有观察到显著差异.

结论:

与静态CVP指导相比,动态IVC引导的液体复苏不会改变败血症患者的死亡率.
动态IVC引导可能会导致减少冲击持续时间和血管压缩器要求.
进一步的研究可能会探索动态液体复苏策略的最佳实施.

关键词:

动态参数是一个动态参数.液体复苏液体复苏复苏复苏死亡率死亡率诺尔阿皮内弗林 (norepinephrine) 是一种非上腺素.这是一种血症.冲击时间冲击持续时间静态参数是一个静态参数.超声波超声波是指超声波的使用.

更多相关视频

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

相关概念视频

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...